Population pharmacokinetics of remlifanserin (ACP-204), a serotonin 2A receptor inverse agonist
{{output}}
Introduction: Remlifanserin, or ACP-204, is a potent serotonin 2A receptor inverse agonist under investigation for treatment of Alzheimer's disease psychosis and Lewy body dementia psychosis. A population pharmacokinetics (popPK... ...
